Pique Therapeutics
Durham, US · North Carolina corporation
Find your way into Pique Therapeutics
Sign up to see every warm intro you have to Pique Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pique Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
KD
Keith DionneNamed on SEC filing
CM
Christopher MeldrumNamed on SEC filing
JB
John B. BrennanNamed on SEC filing
IJ
Ian J. MehrAssistant Secretary
Reported raises · per SEC filings
Form D private placements$854.1K disclosed across 1 round · 2017
▶$854.1KraisedDec 2018 · 13 investors · Biotechnology
▶$854.1KraisedDec 2018 · 13 investors · Biotechnology
Officers, directors & promoters on the filing
- Keith DionneDirector
- Ian J. MehrExecutive Officer
- Christopher MeldrumExecutive Officer, Director
- John B. BrennanDirector
- Offering amount
- $1000K
- Amount sold
- $854.1K
- Minimum investment
- $5K
- First sale
- Jul 2017
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 04
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Pique Therapeutics raised?
- Pique Therapeutics has disclosed $854.1K raised across 1 round.
- Where is Pique Therapeutics headquartered?
- Pique Therapeutics is headquartered in Durham, US.